When applied to AQP1-expressing HT29 colon cancer cells, these inhibitory compounds significantly reduced cancer cell motility (Kourghi et al., 2015), suggesting a physiological role of AQP1 ion conductance in cell migration. The gene discussed is AQP1; the disease is colonic neoplasm.